Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
NCT01287182 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2013-05-21
Summary
This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.
Conditions
Interventions
- DRUG
-
Ateronon
Ateronon daily for 3 months
Sponsors & Collaborators
-
Omicron Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Lebanon
Study Locations
More Related Trials
-
Study of A3309 in Patients With Dyslipidemia
NCT01069783 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
NCT02910778 ·Status: COMPLETED ·Phase: PHASE4
-
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
NCT00141141 ·Status: COMPLETED ·Phase: PHASE4
-
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
NCT01770210 ·Status: COMPLETED
-
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
NCT00418834 ·Status: COMPLETED ·Phase: PHASE3
-
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
NCT00143234 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
NCT00504829 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT01115985 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
NCT00616772 ·Status: COMPLETED ·Phase: PHASE3
-
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
NCT00442845 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Atorvo+™ in Healthy Adult Participants
NCT06615284 ·Status: COMPLETED ·Phase: PHASE1
-
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
NCT00993915 ·Status: COMPLETED
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
NCT07000123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
NCT00251576 ·Status: COMPLETED ·Phase: PHASE3
-
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
NCT00452842 ·Status: TERMINATED
-
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)
NCT00644709 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
NCT02035215 ·Status: UNKNOWN ·Phase: PHASE3
-
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
NCT00327418 ·Status: COMPLETED ·Phase: PHASE4
-
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
NCT00163163 ·Status: COMPLETED ·Phase: PHASE3
-
CKD-337(2) Drug-drug Interaction Study
NCT02422030 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
NCT02579356 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300469 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
NCT00977288 ·Status: COMPLETED ·Phase: PHASE2